| Effectiveness of Covid-19 vaccines in ambulatory and inpatient care settings MG Thompson, E Stenehjem, S Grannis, SW Ball, AL Naleway, TC Ong, ... New England Journal of Medicine 385 (15), 1355-1371, 2021 | 453 | 2021 |
| Waning 2-dose and 3-dose effectiveness of mRNA vaccines against COVID-19–associated emergency department and urgent care encounters and hospitalizations among adults during … JM Ferdinands MMWR. Morbidity and mortality weekly report 71, 2022 | 440 | 2022 |
| Effectiveness of a third dose of mRNA vaccines against COVID-19–associated emergency department and urgent care encounters and hospitalizations among adults during periods of … MG Thompson MMWR. Morbidity and mortality weekly report 71, 2022 | 439 | 2022 |
| A harmonized data quality assessment terminology and framework for the secondary use of electronic health record data MG Kahn, TJ Callahan, J Barnard, AE Bauck, J Brown, BN Davidson, ... Egems 4 (1), 2016 | 390 | 2016 |
| Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA vaccination in preventing COVID-19–associated emergency department and urgent care encounters and hospitalizations among … NP Klein MMWR. Morbidity and mortality weekly report 71, 2022 | 184 | 2022 |
| Effectiveness of 2-dose vaccination with mRNA COVID-19 vaccines against COVID-19–associated hospitalizations among immunocompromised adults—nine states, January–September 2021 PJ Embi MMWR. Morbidity and Mortality Weekly Report 70, 2021 | 170 | 2021 |
| Interim estimates of COVID-19 vaccine effectiveness against COVID-19–associated emergency department or urgent care clinic encounters and hospitalizations among adults during … SJ Grannis MMWR. Morbidity and mortality weekly report 70, 2021 | 166 | 2021 |
| Early estimates of bivalent mRNA vaccine effectiveness in preventing COVID-19–associated emergency department or urgent care encounters and hospitalizations among … MW Tenforde MMWR. Morbidity and mortality weekly report 71, 2022 | 129 | 2022 |
| Laboratory-confirmed COVID-19 among adults hospitalized with COVID-19–like illness with infection-induced or mRNA vaccine-induced SARS-CoV-2 immunity—nine states, January … CH Bozio MMWR. Morbidity and Mortality Weekly Report 70, 2021 | 127 | 2021 |
| Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study JM Ferdinands, S Rao, BE Dixon, PK Mitchell, MB DeSilva, SA Irving, ... bmj 379, 2022 | 125 | 2022 |
| Effectiveness of 2, 3, and 4 COVID-19 mRNA vaccine doses among immunocompetent adults during periods when SARS-CoV-2 Omicron BA. 1 and BA. 2/BA. 2.12. 1 sublineages … R Link-Gelles MMWR. Morbidity and mortality weekly report 71, 2022 | 106 | 2022 |
| From raw data to FAIR data: the FAIRification workflow for health research AA Sinaci, FJ Núñez-Benjumea, M Gencturk, ML Jauer, T Deserno, ... Methods of information in medicine 59 (S 01), e21-e32, 2020 | 79 | 2020 |
| Linguistic characteristics of shill reviews T Ong, M Mannino, D Gregg Electronic Commerce Research and Applications 13 (2), 69-78, 2014 | 71 | 2014 |
| Effectiveness of COVID-19 mRNA vaccines against COVID-19–associated hospitalizations among immunocompromised adults during SARS-CoV-2 Omicron predominance—VISION Network, 10 … A Britton MMWR. Morbidity and Mortality Weekly Report 71, 2022 | 61 | 2022 |
| Improving record linkage performance in the presence of missing linkage data TC Ong, MV Mannino, LM Schilling, MG Kahn Journal of biomedical informatics 52, 43-54, 2014 | 54 | 2014 |
| Dynamic-ETL: a hybrid approach for health data extraction, transformation and loading TC Ong, MG Kahn, BM Kwan, T Yamashita, E Brandt, P Hosokawa, ... BMC medical informatics and decision making 17, 1-12, 2017 | 52 | 2017 |
| Real World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients AAG Neil R. Aggarwal, Laurel E. Beaty, Tellen D. Bennett, Nichole E. Carlson ... The Journal of Infectious Diseases, 2022 | 49 | 2022 |
| Estimates of bivalent mRNA vaccine durability in preventing COVID-19–associated hospitalization and critical illness among adults with and without immunocompromising conditions … R Link-Gelles MMWR. Morbidity and Mortality Weekly Report 72, 2023 | 48 | 2023 |
| Effectiveness of homologous and heterologous COVID-19 booster doses following 1 Ad. 26. COV2. S (Janssen [Johnson & Johnson]) vaccine dose against COVID-19–associated emergency … K Natarajan MMWR. Morbidity and Mortality Weekly Report 71, 2022 | 47 | 2022 |
| Estimation of COVID-19 mRNA vaccine effectiveness against medically attended COVID-19 in pregnancy during periods of Delta and Omicron variant predominance in the United States SJ Schrag, JR Verani, BE Dixon, JM Page, KA Butterfield, M Gaglani, ... JAMA network open 5 (9), e2233273-e2233273, 2022 | 41 | 2022 |
